Clinical Trial

A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults

Name: A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults — clinical trial record (NCT07143448)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Phase 1b Study of HS235 Assessing the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of the Activin Signaling Inhibitor HS235 Added to Background Treatment in Adults with Pulmonary Arterial Hypertension (PAH)

Trial Details

NCT Number	NCT07143448
Lead Sponsor	35Pharma Inc
Conditions	Pulmonary Arterial Hypertension
Enrollment	40 participants
Start Date	2025-10
Primary Completion	2027-04 (estimated)
Study Completion	2028-01 (estimated)
Updated on ClinicalTrials.gov	2025-08-27